Fluorescent imaging probes for in vivo ovarian cancer targeted detection and surgery
Medicinal Research Reviews · 2024-07 · 44 (4) · 1800-1866
DOI: 10.1002/med.22027 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medicinal Research Reviews, online erschienen am 17.02.2024. Verfasst von Roberta Solidoro und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy-Pharmaceutical Sciences, University of Bari, Bari, Italy. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Fluorescent Dyes, Optical Imaging. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 236 Literaturangaben. Gefördert von: Associazione Italiana per la Ricerca sul Cancro, Ministero dello Sviluppo Economico.
Abstract (Originalsprache)
Ovarian cancer is the most lethal gynecological cancer, with a survival rate of approximately 40% at five years from the diagno. The first‐line treatment consists of cytoreductive surgery combined with chemotherapy (platinum‐ and taxane‐based drugs). To date, the main prognostic factor is related to the complete surgical resection of tumor lesions, including occult micrometastases. The presence of minimal residual diseases not detected by visual inspection and palpation during surgery significantly increases the risk of disease relapse. Intraoperative fluorescence imaging systems have the potential to improve surgical outcomes. Fluorescent tracers administered to the patient may support surgeons for better real‐time visualization of tumor lesions during cytoreductive procedures. In the last decade, consistent with the discovery of an increasing number of ovarian cancer‐specific targets, a wide range of fluorescent agents were identified to be employed for intraoperatively detecting ovarian cancer. Here, we present a collection of fluorescent probes designed and developed for fluorescence‐guided ovarian cancer surgery. Original articles published between 2011 and November 2022 focusing on fluorescent probes, currently under preclinical and clinical investigation, were searched in PubMed. The keywords used were targeted detection, ovarian cancer, fluorescent probe, near‐infrared fluorescence, fluorescence‐guided surgery , and intraoperative imaging . All identified papers were English‐language full‐text papers, and probes were classified based on the location of the biological target: intracellular, membrane, and extracellular.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy-Pharmaceutical Sciences, University of Bari, Bari, Italy.
ORCID-Profile: Morena Miciaccia, Antonio Scilimati
Förderung
- Associazione Italiana per la Ricerca sul Cancro
- Ministero dello Sviluppo Economico
Zitieren
APA
Solidoro, R., Centonze, A., Miciaccia, M., Baldelli, O. M., Armenise, D., Ferorelli, S., Perrone, M. G., & Scilimati, A. (2024). Fluorescent imaging probes for in vivo ovarian cancer targeted detection and surgery. Medicinal Research Reviews, 44(4), 1800-1866. https://doi.org/10.1002/med.22027
Vancouver
Solidoro R, Centonze A, Miciaccia M, Baldelli OM, Armenise D, Ferorelli S, et al. Fluorescent imaging probes for in vivo ovarian cancer targeted detection and surgery. Medicinal Research Reviews. 2024;44(4):1800-1866. doi:10.1002/med.22027
BibTeX
@article{Solidoro2024,
author = {Solidoro, Roberta and Centonze, Antonella and Miciaccia, Morena and Baldelli, Olga Maria and Armenise, Domenico and Ferorelli, Savina and Perrone, Maria Grazia and Scilimati, Antonio},
title = {Fluorescent imaging probes for in vivo ovarian cancer targeted detection and surgery},
journal = {Medicinal Research Reviews},
year = {2024},
volume = {44},
number = {4},
pages = {1800--1866},
doi = {10.1002/med.22027}
}
EUVIMED